Recursion Pharmaceuticals (RXRX) Earnings Date, Estimates & Call Transcripts → my top trade on these 9 tickers (From DTI) (Ad) Free RXRX Stock Alerts $10.17 -0.15 (-1.45%) (As of 03/27/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateMay. 13EstimatedActual EPS (Feb. 27) -$0.40 Beat By $0.06 Consensus EPS (Feb. 27) -$0.46 Get Recursion Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for RXRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRXRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RXRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaAltcoin FRENZY Alert…Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days… Click here now to register for the event (FOR FREE!) Recursion Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.41)($0.33)($0.37)Q2 20242($0.41)($0.33)($0.37)Q3 20242($0.41)($0.35)($0.38)Q4 20242($0.83)($0.40)($0.62)FY 20248($2.06)($1.41)($1.74)RXRX Earnings Date and InformationRecursion Pharmaceuticals last posted its quarterly earnings data on February 27th, 2024. The reported ($0.40) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.46) by $0.06. The firm had revenue of $10.89 million for the quarter, compared to analysts' expectations of $12.37 million. Recursion Pharmaceuticals has generated ($1.55) earnings per share over the last year (($1.55) diluted earnings per share). Earnings for Recursion Pharmaceuticals are expected to grow in the coming year, from ($1.63) to ($1.50) per share. Recursion Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off prior year's report dates.Read More Recursion Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/13/2024Estimated)------- 2/27/2024Q4 2023($0.46)($0.40)+$0.06($0.40)$12.37 million$10.89 million11/9/2023Q3 2023($0.38)($0.43)($0.05)($0.43)$12.20 million$10.53 million8/8/2023Q2 2023($0.38)($0.38)-($0.38)$10.43 million$11.02 million5/8/2023Q1 2023($0.35)($0.34)+$0.01($0.34)$15.93 million$12.13 million2/27/2023Q4 2022($0.15)($0.31)($0.16)($0.31)$66.68 million$13.68 million11/8/2022Q3 2022($0.36)($0.35)+$0.01($0.35)$6.43 million$13.16 million Get the Latest News and Ratings for RXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($0.35)($0.38)($0.03)($0.38)$5.60 million$7.67 million5/10/2022Q1 2022$0.51($0.33)($0.84)($0.33)$152.90 million$5.33 million3/23/2022Q4 2021($0.30)($0.38)($0.08)($0.38)$7.62 million$2.53 million11/10/2021Q3 2021($0.28)($0.28)-($0.28)$2.62 million$2.53 million8/12/2021Q2 2021($0.23)($0.31)($0.08)($0.31)$2.65 million$2.55 million5/12/2021Q1 2021($0.24)($1.33)($1.09)($1.33)-$2.56 million Recursion Pharmaceuticals Earnings - Frequently Asked Questions When is Recursion Pharmaceuticals's earnings date? Recursion Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 13th, 2024 based off last year's report dates. Learn more on RXRX's earnings history. Did Recursion Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Recursion Pharmaceuticals (NASDAQ:RXRX) reported ($0.40) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.46) by $0.06. Learn more on analysts' earnings estimate vs. RXRX's actual earnings. How much revenue does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded annual revenue of $44.58 million. How much profit does Recursion Pharmaceuticals generate each year? Recursion Pharmaceuticals (NASDAQ:RXRX) has a recorded net income of -$328.07 million. RXRX has generated -$1.55 earnings per share over the last four quarters. What is Recursion Pharmaceuticals's EPS forecast for next year? Recursion Pharmaceuticals's earnings are expected to grow from ($1.63) per share to ($1.50) per share in the next year. More Earnings Resources from MarketBeat Related Companies: KYMR Earnings Date VCEL Earnings Date DNA Earnings Date PTCT Earnings Date BEAM Earnings Date SANA Earnings Date DNLI Earnings Date NMRA Earnings Date TWST Earnings Date SDGR Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Lululemon Stock Implodes Post Earnings, Guidance Muted Applied Optoelectronics earnings dumper, pain now for gain later?Is Roku worth a second look after the earnings panic selloff?Dell Technologies breaks out ahead of earnings releaseNovavax’s dispute resolution and upcoming earnings callImpinj stock surges on strong earnings and guidanceAirbnb stock bulls just went all in before earnings This page (NASDAQ:RXRX) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recursion Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.